Home Other Building Blocks 4682-36-4
4682-36-4,MFCD00079197
Catalog No.:AA019FPO

4682-36-4 | Orphenadrine citrate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$27.00   $19.00
- +
5g
98%
in stock  
$75.00   $53.00
- +
25g
98%
in stock  
$255.00   $178.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA019FPO
Chemical Name:
Orphenadrine citrate
CAS Number:
4682-36-4
Molecular Formula:
C24H31NO8
Molecular Weight:
461.5048
MDL Number:
MFCD00079197
SMILES:
OC(=O)CC(C(=O)O)(CC(=O)O)O.CN(CCOC(c1ccccc1C)c1ccccc1)C
NSC Number:
757238
Properties
Computed Properties
 
Complexity:
488  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
11  
Undefined Atom Stereocenter Count:
1  

Literature

Title: Liver tumor promoting effect of orphenadrine in rats and its possible mechanism of action including CAR activation and oxidative stress.

Journal: The Journal of toxicological sciences 20130101

Title: Enhanced liver tumor promotion activity in rats subjected to combined administration of phenobarbital and orphenadrine.

Journal: The Journal of toxicological sciences 20130101

Title: Cu(II)-catalyzed asymmetric hydrosilylation of diaryl- and aryl heteroaryl ketones: application in the enantioselective synthesis of orphenadrine and neobenodine.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20120611

Title: [Interaction of drugs with the primary disease - when medicines exacerbate illnesses].

Journal: Praxis 20120314

Title: Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study.

Journal: Audiology & neuro-otology 20120101

Title: Validated stability-indicating reversed-phase-HPLC method for simultaneous determination of orphenadrine citrate, caffeine and aspirin.

Journal: Chemical & pharmaceutical bulletin 20120101

Title: Orphenadrine induces secondarily generalized convulsive status epilepticus in rats.

Journal: Brain research bulletin 20110405

Title: A predictive ligand-based Bayesian model for human drug-induced liver injury.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20101201

Title: Full recovery from a potentially lethal dose of orphenadrine ingestion using conservative treatment: a case report.

Journal: Human & experimental toxicology 20101101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial.

Journal: Wiener medizinische Wochenschrift (1946) 20101101

Title: Determination of orphenadrine plasma levels using HPLC with diode array detection and a novel solid-phase extraction procedure in psychiatric patients.

Journal: Journal of pharmaceutical and biomedical analysis 20091015

Title: The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine.

Journal: British journal of clinical pharmacology 20090801

Title: The first asymmetric halogen/metal-exchange reaction: desymmetrization of alcohols with enantiotopic bromoarene substituents.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20090706

Title: Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine.

Journal: Pain 20090401

Title: The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.

Journal: British journal of clinical pharmacology 20090201

Title: Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.

Journal: The Journal of pharmacy and pharmacology 20090101

Title: Influence of orphenadrine upon the protective activity of various antiepileptics in the maximal electroshock-induced convulsions in mice.

Journal: Pharmacological reports : PR 20090101

Title: Pharmacokinetic, metabolism and withdrawal time of orphenadrine in camels (Camelus dromedarius) after intravenous administration.

Journal: Research in veterinary science 20081201

Title: [Diclofenac/orphenadrine as a combined analgetic in post-operative relief of pain].

Journal: Orvosi hetilap 20080928

Title: Effect of warnings in a medical journal on the use of orphenadrine.

Journal: Journal of evaluation in clinical practice 20080801

Title: Are there alternatives to the use of quinine to treat nocturnal leg cramps?

Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20080201

Title: Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.

Journal: The Journal of pharmacy and pharmacology 20080101

Title: Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20071201

Title: Determination of paracetamol and orphenadrine citrate in pharmaceutical tablets by modeling of spectrophotometric data using partial least-squares and artificial neural networks.

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20071001

Title: Evaluation of enantioselective binding of antihistamines to human serum albumin by ACE.

Journal: Electrophoresis 20070801

Title: [Enzyme kinetics of schizandrin metabolism and sex differences in rat liver microsomes].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20070701

Title: Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.

Journal: Archives of gerontology and geriatrics 20070101

Title: Propofol metabolism is enhanced after repetitive ketamine administration in rats: the role of cytochrome P-450 2B induction.

Journal: British journal of anaesthesia 20060901

Title: Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20060901

Title: Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060901

Title: Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS).

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060724

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine.

Journal: International journal of clinical practice 20060501

Title: Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels.

Journal: Journal of pharmaceutical sciences 20060401

Title: Dimemorfan N-demethylation by mouse liver microsomal cytochrome P450 enzymes.

Journal: Life sciences 20050701

Title: Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin.

Journal: Drugs in R&D 20050101

Title: Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.

Journal: Experimental neurology 20041001

Title: Objective high-frequency tinnitus of middle-ear myoclonus.

Journal: The Journal of laryngology and otology 20040301

Title: [Diclofenac 75mg. and 30 mg. orfenadine (Neodolpasse) versus placebo and piroxicam in postoperative analgesia after arthroscopy].

Journal: Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 20040101

Title: Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers.

Journal: Arzneimittel-Forschung 20040101

Title: Upregulation of cytochromes P450 2B in rat liver by orphenadrine.

Journal: British journal of pharmacology 20030601

Title: Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine.

Journal: Journal of neurotrauma 20030601

Title: Therapeutic response of benzodiazepine, orphenadrine citrate and occlusal splint association in TMD pain.

Journal: Cranio : the journal of craniomandibular practice 20030401

Title: Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.

Journal: Psychopharmacology 20030201

Title: Spectrophotometric determination of phenylephrine HCl and orphenadrine citrate in pure and in dosage forms.

Journal: Journal of pharmaceutical and biomedical analysis 20021107

Title: Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity.

Journal: Amino acids 20020101

Title: Acute intoxication with orphenadrine and clozapine.

Journal: Forensic science international 20011115

Title: Non-sustained ventricular tachycardia due to low-dose orphenadrine.

Journal: The American journal of medicine 20011001

Title: Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.

Journal: British journal of anaesthesia 20010401

Title: Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.

Journal: British journal of pharmacology 20010201

Title: [Experience gained with the drug amizon in the treatment of patients with mumps, with special reference to its effects on some biochemical markers].

Journal: Likars'ka sprava 20010101

Title: [Diagnostic image (17). Acute dystonia induced by prochlorperazine].

Journal: Nederlands tijdschrift voor geneeskunde 20001223

Title: Examination of purported probes of human CYP2B6.

Journal: Pharmacogenetics 19970601

Title: Reversal of orphenadrine-induced ventricular tachycardia with physostigmine.

Journal: The Journal of emergency medicine 19910101

Title: Mental impairment in Parkinson's disease. The role of anticholinergic drugs.

Journal: Acta psychiatrica Belgica 19840101

Title: [Orphenadrine poisoning].

Journal: Ugeskrift for laeger 19810316

Title: An extrapyramidal syndrome after lithium therapy.

Journal: The British journal of psychiatry : the journal of mental science 19800201

Title: A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy.

Journal: The Journal of international medical research 19760101

Title: Visual hallucinations and delirium during treatment with amantadine (Symmetrel).

Journal: Journal of the American Geriatrics Society 19750501

Title: [Pilot study on the effects of an antiparkinson anticholinergic agent during depressive conditions].

Journal: L'Encephale 19750101

Title: Abnormal involuntary movements induced by anticholinergic therapy.

Journal: Acta neurologica Scandinavica 19740101

Title: Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.

Journal: The American journal of psychiatry 19730701

Title: Haloperidol-desipramine interaction in mice, rats and man.

Journal: Chemico-biological interactions 19700801

Title: A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.

Journal: The British journal of psychiatry : the journal of mental science 19660601

Title: Kornhuber, J., et al., Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies. J Neural Transm Gen Sect, 1995. 102(3): p. 237-46.

Title: Pubill, D., et al., Assessment of the adrenergic effects of orphenadrine in rat vas deferens. J Pharm Pharmacol, 1999. 51(3): p. 307-12.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 4682-36-4
Tags:4682-36-4 Molecular Formula|4682-36-4 MDL|4682-36-4 SMILES|4682-36-4 Orphenadrine citrate